Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
331
331 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- certepetideCEND-1, LSTA1Phase 21 trial
Lisata Therapeutics, Inc. · Cholangiocarcinoma, Gallbladder Cancer, Gallbladder Carcinoma
- CM338Phase 21 trial
Keymed Biosciences Co.Ltd · IgA Nephropathy
- CP-383Phase 21 trial
Tasca Therapeutics · Solid Tumor Malignancies, Colorectal Carcinoma, Small Cell Lung Cancer ( SCLC )
- CRG-150Phase 21 trial
CoRegen, Inc. · HR-positive, HER2-negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Prostate Cancer
- CU01-1001Phase 21 trial
Curacle Co., Ltd. · Diabetic Nephropathies
- Debio 4228Phase 21 trial
Debiopharm International SA · Prostate Cancer
- DM002Phase 21 trial
Xadcera Biopharmaceutical (Suzhou) Co., Ltd. · Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms
- EB-701CA9-NKPhase 21 trial
Beijing Biotech · Advanced or Metastatic Clear Cell Renal Cell Carcinoma
- EG-70Phase 21 trial
enGene, Inc. · Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
- ETX-19477Phase 21 trial
858 Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer
- EVER001Phase 21 trial
Everest Medicines (China) Co.,Ltd. · Minimal Change Disease (MCD), IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS)
- FG-3246FOR46Phase 21 trial
Kyntra Bio · Metastatic Castration-Resistant Prostate Cancer
- FOG-001Phase 21 trial
Parabilis Medicines, Inc. · Cancer, Colorectal Cancer, Solid Tumor
- FT819Phase 21 trial
Fate Therapeutics · Lupus Nephritis, Systemic Lupus Erythematosus, SLE - Systemic Lupus Erythematosus
- Ga-68-NGULPhase 21 trial
Cellbion Co., Ltd. · Prostate Cancer, mCRPC
- GDC-1261Phase 21 trial
Roche (Genentech) · Advanced Prostate Cancer, Metastatic Prostate Cancer
- GI-101Phase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer
- GI-101APhase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer
- GI-108Phase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC)
- GM103Phase 21 trial
GeneMedicine Co., Ltd. · Head and Neck Cancer, Malignant Melanoma, Colorectal Cancer
- GSK5458514Phase 21 trial
GSK · Neoplasms, Prostate
- GSK5471713Phase 21 trial
GSK · Neoplasms, Prostate
- GVV858Phase 21 trial
Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer
- HLX01Phase 21 trial
Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)
- HLX79Phase 21 trial
Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)
- HP518Phase 21 trial
Hinova Pharmaceuticals Inc. · Metastatic Castration-resistant Prostate Cancer
- HRS-1738Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · PET Imaging in Patients With Prostate Cancer
- HS-10390Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Kidney Disease
- HS-10516Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Advanced Clear Cell Renal Cell Carcinoma
- HS-10566Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · High-risk Non-muscle-invasive Bladder Cancer
- IAM1363Phase 21 trial
Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer
- IBR854Phase 21 trial
Imbioray (Hangzhou) Biomedicine Co., Ltd. · Renal Cell Carcinoma (RCC)
- IG3018Phase 21 trial
Intelligem Therapeutics Australia Pty Ltd. · Hyperuricemia, Hypouricemia, Renal
- IGT-303Phase 21 trial
Ingenia Therapeutics INC · Healthy Volunteers, Chronic Kidney Disease
- INV-9956Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Advanced Metastatic Castration Resistant Prostate Cancer
- JMT601Phase 21 trial
Shanghai JMT-Bio Inc. · Primary Membranous Nephropathy
- KELI-101Phase 21 trial
Kelifarma · Preemptive Therapy of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery
- KJ103Phase 21 trial
Shanghai Bao Pharmaceuticals Co., Ltd. · Anti-Glomerular Basement Membrane Disease
- KP104Phase 21 trial
Kira Pharmacenticals (US), LLC. · Glomerulonephritis
- KVA12123Phase 21 trial
Kineta Inc. · Cancer, Solid Tumor, Melanoma
- LLX-424Phase 21 trial
Lilac Therapeutics, Inc. · Kidney Stones
- LSALT PeptideMetablokPhase 21 trial
Arch Biopartners Inc. · Acute Kidney Injury, Cardiac Surgery
- Lu-177-DGULPhase 21 trial
Cellbion Co., Ltd. · Prostate Cancer, mCRPC
- MHB048CPhase 21 trial
Minghui Pharmaceutical (Hangzhou) Ltd · mCRPC (Metastatic Castration-resistant Prostate Cancer), Advanced Malignant Solid Tumor
- MIL116Phase 21 trial
Beijing Mabworks Biotech Co., Ltd. · Immunoglobulin A Nephropathy
- MZE829Phase 21 trial
Maze Therapeutics · Proteinuric Kidney Disease
- NBIP-01435Phase 21 trial
Neurocrine Biosciences · Congenital Adrenal Hyperplasia
- NDI-101150Phase 21 trial
Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- NUV-1511Phase 21 trial
Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- preferred combination of tinengotinibPhase 21 trial
TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.